TPP1
TPP1 (tripeptidyl peptidase 1, also known as TPP-1, CLN2, LPIC and SCAR7) is a lysosomal serine protease that removes tripeptides from the N-terminus of its substrates. It belongs to the sedolisin family and is linked to late-infantile neuronal ceroid lipofuscinosis. Browse Assay Genie's current range of TPP1 research reagents below, or read on for the biology behind the target.
TPP1 is a lysosomal serine protease with tripeptidyl-peptidase I activity. It cleaves N-terminal tripeptides from substrates and has weaker endopeptidase activity. It requires substrates with an unsubstituted N-terminus, and it may act as a non-specific lysosomal peptidase that generates tripeptides from the breakdown products of other lysosomal proteinases.
The TPP1 gene encodes a member of the sedolisin family of serine proteases. The enzyme is synthesised as a catalytically inactive precursor. Acidification activates it and triggers auto-proteolysis, which fits its role in the acidic lysosomal compartment. UniProt lists its subcellular locations as the lysosome and the melanosome. Mouse and rat both carry a Tpp1 ortholog, which is useful for comparative and model-organism work.
Mutations in the TPP1 gene cause late-infantile neuronal ceroid lipofuscinosis. This is associated with failure to degrade specific neuropeptides and a subunit of ATP synthase in the lysosome. The gene's former names reflect this history: ceroid-lipofuscinosis, neuronal 2, late infantile (Jansky-Bielschowsky disease), and spinocerebellar ataxia, autosomal recessive 7. The symbol CLN2 and the name tripeptidyl peptidase I are still widely used in the literature, so searches for TPP1 often need these aliases as well.
TPP1 mutations cause late-infantile neuronal ceroid lipofuscinosis, making the enzyme a central subject in studies of this lysosomal storage disorder.
TPP1 generates tripeptides from the breakdown products of other lysosomal proteinases, so it is studied in protein turnover within the lysosome.
Loss of TPP1 is associated with failure to degrade specific neuropeptides, which links the enzyme to neuronal substrate handling.
TPP1 is made as an inactive precursor that is activated and auto-proteolysed on acidification, providing a model for zymogen processing.
TPP1 is a lysosomal serine protease with tripeptidyl-peptidase I activity. It cleaves N-terminal tripeptides from substrates with an unsubstituted N-terminus and has weaker endopeptidase activity. It may act as a non-specific lysosomal peptidase on the breakdown products of other lysosomal proteinases.
TPP1 is also called TPP-1, CLN2, LPIC and SCAR7, and the protein is named tripeptidyl-peptidase 1 or tripeptidyl peptidase I. Earlier gene names were ceroid-lipofuscinosis, neuronal 2, late infantile (Jansky-Bielschowsky disease) and spinocerebellar ataxia, autosomal recessive 7.
Mutations in the TPP1 gene result in late-infantile neuronal ceroid lipofuscinosis. Mouse and rat each have a Tpp1 ortholog. Check the datasheet of any product for its validated reactivity.
Other targets with similar abbreviations; note that TPPP proteins are distinct from the lysosomal protease TPP1.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O14773; product specifications from Assay Genie datasheets.